Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (371-380 of 438) with videos related to

Pageof 44
Sort By:
The Journal of Allergy and Clinical Immunology|September 28, 2025
Late effects after hematopoietic stem cell transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP, and TCWP EBMT StudyKim Ramme, AnnaCarin Horne, Karin Beutel, et al.
Blood|April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosisBernd Hartz, Rebecca Marsh, Kanchan Rao, et al.
Haematologica|February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemiaSandra Preuner, Christina Peters, Ulrike Pötschger, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Cancer Research|April 19, 2017
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic StrategiesMai H Bui, Xiaoyu Lin, Daniel H Albert, et al.
Bone Marrow Transplantation|October 30, 2012
Allo-SCT using BU, CY and melphalan for children with AML in second CRR Beier, M H Albert, P Bader, et al.
British Journal of Haematology|November 9, 2023
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workupSenthilkumar Ramamoorthy, Dirk Lebrecht, Denny Schanze, et al.
Journal of Human Immunity|July 9, 2026
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMTGiulia Prunotto, Marie Parreillet, Bénédicte Neven, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Journal of Clinical Immunology|August 15, 2015
Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective AnalysisBeata Wolska-Kuśnierz, Hanna Gregorek, Krystyna Chrzanowska, et al.
Pageof 44

Showing results (371-380 of 438) with videos related to

Sort By:
Pageof 44
The Journal of Allergy and Clinical Immunology|September 28, 2025
Late effects after hematopoietic stem cell transplantation in patients with HLH: A Histiocyte Society, PDWP, IEWP, and TCWP EBMT StudyKim Ramme, AnnaCarin Horne, Karin Beutel, et al.
Blood|April 22, 2016
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosisBernd Hartz, Rebecca Marsh, Kanchan Rao, et al.
Haematologica|February 13, 2016
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemiaSandra Preuner, Christina Peters, Ulrike Pötschger, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Discovery and characterization of the potent, selective and orally bioavailable MMP inhibitor ABT-770M L Curtin, A S Florjancic, H R Heyman, et al.
Cancer Research|April 19, 2017
Preclinical Characterization of BET Family Bromodomain Inhibitor ABBV-075 Suggests Combination Therapeutic StrategiesMai H Bui, Xiaoyu Lin, Daniel H Albert, et al.
Bone Marrow Transplantation|October 30, 2012
Allo-SCT using BU, CY and melphalan for children with AML in second CRR Beier, M H Albert, P Bader, et al.
British Journal of Haematology|November 9, 2023
Biallelic inactivation of the NF1 tumour suppressor gene in juvenile myelomonocytic leukaemia: Genetic evidence of driver function and implications for diagnostic workupSenthilkumar Ramamoorthy, Dirk Lebrecht, Denny Schanze, et al.
Journal of Human Immunity|July 9, 2026
TTC7A deficiency: A retrospective international study on treatment and outcomes from the Inborn Errors Working Party of EBMTGiulia Prunotto, Marie Parreillet, Bénédicte Neven, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Journal of Clinical Immunology|August 15, 2015
Nijmegen Breakage Syndrome: Clinical and Immunological Features, Long-Term Outcome and Treatment Options - a Retrospective AnalysisBeata Wolska-Kuśnierz, Hanna Gregorek, Krystyna Chrzanowska, et al.
Pageof 44